25.07.2017 12:51:06

Quest Diagnostics Reports 15% Advance In Q2 Profit

(RTTNews) - Quest Diagnostics (DGX) revealed earnings for its second quarter that gained ground from last year.

The company said its bottom line rose to $204 million, or $1.55 per share. This was up from $178 million, or $1.34 per share, in last year's second quarter.

Analysts had expected the company to earn $1.42 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 1.6% to $1.94 billion. This was up from $1.91 billion last year.

Quest Diagnostics earnings at a glance:

-Earnings (Q2): $204 Mln. vs. $178 Mln. last year. -Earnings Growth (Y-o-Y): 14.6% -EPS (Q2): $1.55 vs. $1.34 last year. -EPS Growth (Y-o-Y): 15.7% -Analysts Estimate: $1.42 -Revenue (Q2): $1.94 Bln vs. $1.91 Bln last year. -Revenue Change (Y-o-Y): 1.6%

-Guidance: Full year EPS guidance: $5.62 - $5.72 Full year revenue guidance: $7.69 - $7.74 Bln

Analysen zu Quest Diagnostics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Quest Diagnostics Inc. 145,30 0,10% Quest Diagnostics Inc.